Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases

Author(s): Guilherme Felipe dos Santos Fernandes , Aline Renata Pavan , Jean Leandro dos Santos* .

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 12 , 2018

Abstract:

Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.

Keywords: Heterocyclic N-oxides, N-oxide compounds, tuberculosis, malaria, neglected tropical diseases, leishmaniasis, Chagas disease, drug discovery.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 24
ISSUE: 12
Year: 2018
Page: [1325 - 1340]
Pages: 16
DOI: 10.2174/1381612824666180417122625
Price: $58

Article Metrics

PDF: 36
HTML: 5
EPUB: 2